Advertising

Atossa Therapeutics

ATOS-Q

NASDAQ:ATOS

4.18
0.07 (1.70%)
Atossa Therapeutics NASDAQ: ATOS is a Seattle-based clinical-stage biopharmaceutical company. Atossa’s current focus is on breast cancer and COVID-19. Dr. Steven Quay, a physician specializing in biological chemistry, founded Atossa in 2009.
More at Wikipedia

Analysis and Opinions about ATOS-Q

Signal
Opinion
Expert
Chart
BUY
BUY
July 13, 2021
Allan Tong’s Discover Picks Two analysts rate ATOS stock a buy with a price target of $7.50 or 41% upside. Again, this is purely a speculative play and a volatile one with a 2.21 beta though it is a recovery stock. Fundamentals are spotty with insufficient data on Atossa’s margins and price earnings, so you’re betting on AT-H201, much like the market was wagering on who would win the vaccine sweepstakes 16 months ago. Read 3 Post-Covid Recovery Stocks to Buy for our full analysis.
Show full opinionHide full opinion
Allan Tong’s Discover Picks Two analysts rate ATOS stock a buy with a price target of $7.50 or 41% upside. Again, this is purely a speculative play and a volatile one with a 2.21 beta though it is a recovery stock. Fundamentals are spotty with insufficient data on Atossa’s margins and price earnings, so you’re betting on AT-H201, much like the market was wagering on who would win the vaccine sweepstakes 16 months ago. Read 3 Post-Covid Recovery Stocks to Buy for our full analysis.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Atossa Therapeutics(ATOS-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Atossa Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Atossa Therapeutics(ATOS-Q) Frequently Asked Questions

What is Atossa Therapeutics stock symbol?

Atossa Therapeutics is a American stock, trading under the symbol ATOS-Q on the NASDAQ (ATOS). It is usually referred to as NASDAQ:ATOS or ATOS-Q

Is Atossa Therapeutics a buy or a sell?

In the last year, 1 stock analyst published opinions about ATOS-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Atossa Therapeutics.

Is Atossa Therapeutics a good investment or a top pick?

Atossa Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Atossa Therapeutics.

Why is Atossa Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Atossa Therapeutics worth watching?

In the last year, there was no coverage of Atossa Therapeutics published on Stockchase.

What is Atossa Therapeutics stock price?

On 2021-07-23, Atossa Therapeutics (ATOS-Q) stock closed at a price of $4.18.